Purpose of the Test
- Assess the risk of epithelial ovarian cancer
- Differentiate between benign and malignant pelvic masses
- Guide high-risk patients to specialized oncological surgeons
Book ROMA Index Test in Saudi Arabia | Lahalak Medical Platform
An advanced diagnostic tool combining HE4 and CA-125 biomarkers to accurately assess the risk of ovarian malignancy, ensuring early detection and personalized medical care for your gynecological health.
Scientific name: Risk of Ovarian Malignancy Algorithm (ROMA Index)
A specialized laboratory test that calculates the likelihood of ovarian cancer in women with pelvic masses by integrating HE4 and CA-125 levels with menopausal status.
Service type
Laboratory test
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- HE4 protein measurement
- CA-125 cancer antigen measurement
- ROMA score calculation
Medical Service Information
Target Groups
- Women diagnosed with a pelvic mass
- Pre-menopausal and post-menopausal women with clinical suspicion
- High-risk pregnancy cases requiring detailed monitoring
Importance of ROMA Index
- Higher sensitivity than using CA-125 alone
- Reduces false-negative results in early-stage cancer
- Assists in early surgical and therapeutic planning
Conditions & Notices
- Must specify if the patient is pre-menopausal or post-menopausal
Medical services you might also like
